Healthcare -
Biotechnology - NASDAQ - US
$ 6.16
-0.324 %
$ 276 M
Market Cap
-11.41
P/E
YMAB - SHORT-TERM DEBT
Short-term Debt YMAB - Y-mAbs Therapeutics, Inc.
902 K
LAST VALUE
-49.71%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR